The Lancet Gastroenterology and Hepatology




One-year access to more than 500 world journals available in the system
    http://medilib.ir
  • Duration of Time : 365 Day
  • Price : 300$
  • Special Price : 100$
Order
Journals package 3months
    http://medilib.ir
  • Duration of Time : 93 Day
  • Price : 100$
  • Special Price : 50$
Order

Breaking the cycle: time to invest in IBS

doi : 10.1016/S2468-1253(25)00130-X

Volume 10, Issue 6, June 2025, Page 491

Buy The Package and View The Article Online


U-ACTIVATE long-term efficacy and safety outcomes for upadacitinib in ulcerative colitis

doi : 10.1016/S2468-1253(25)00046-9

Buy The Package and View The Article Online


Expanding the menu of dietary therapies in irritable bowel syndrome

doi : 10.1016/S2468-1253(25)00070-6

Buy The Package and View The Article Online


Gut–brain neuromodulators for IBS: what's in a name?

doi : 10.1016/S2468-1253(25)00100-1

Buy The Package and View The Article Online


Appendicectomy: a novel treatment for ulcerative colitis?

doi : 10.1016/S2468-1253(25)00065-2

Buy The Package and View The Article Online


The urgent need for implementation science to achieve hepatitis C elimination

doi : 10.1016/S2468-1253(25)00050-0

Buy The Package and View The Article Online


Retraction and republication—Endoscopic ultrasonography-guided gastroenterostomy versus uncovered duodenal metal stenting for unresectable malignant gastric outlet obstruction (DRA-GOO): a multicentre randomised controlled trial

doi : 10.1016/S2468-1253(25)00135-9

Buy The Package and View The Article Online


Inclusion of patients with isolated ulcerative proctitis in clinical trials

doi : 10.1016/S2468-1253(25)00108-6

Buy The Package and View The Article Online


The pitfalls and promises of scoping reviews in gastroenterology literature

doi : 10.1016/S2468-1253(25)00098-6

Buy The Package and View The Article Online


The pitfalls and promises of scoping reviews in gastroenterology literature – Authors’ reply

doi : 10.1016/S2468-1253(25)00132-3

Buy The Package and View The Article Online



Long-term efficacy and safety of upadacitinib in patients with moderately to severely active ulcerative colitis: an interim analysis of the phase 3 U-ACTIVATE long-term extension study

doi : 10.1016/S2468-1253(25)00017-2

Buy The Package and View The Article Online


Efficacy of dietary interventions in irritable bowel syndrome: a systematic review and network meta-analysis

doi : 10.1016/S2468-1253(25)00054-8

Buy The Package and View The Article Online


Efficacy of gut–brain neuromodulators in irritable bowel syndrome: an updated systematic review and meta-analysis

doi : 10.1016/S2468-1253(25)00051-2

Buy The Package and View The Article Online


Appendicectomy plus standard medical therapy versus standard medical therapy alone for maintenance of remission in ulcerative colitis (ACCURE): a pragmatic, open-label, international, randomised trial

doi : 10.1016/S2468-1253(25)00026-3

Buy The Package and View The Article Online


Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO/ARO/AIO-16): an open-label, multicentre, single-arm, phase 2 trial

doi : 10.1016/S2468-1253(25)00049-4

Buy The Package and View The Article Online


Endoscopic ultrasonography-guided gastroenterostomy versus uncovered duodenal metal stenting for unresectable malignant gastric outlet obstruction (DRA-GOO): a multicentre randomised controlled trial

doi : 10.1016/S2468-1253(25)00136-0

Buy The Package and View The Article Online


The intestinal barrier: a pivotal role in health, inflammation, and cancer

doi : 10.1016/S2468-1253(24)00390-X

Buy The Package and View The Article Online


Prevention and interception trials in inflammatory bowel disease: an international taskforce assessment on clinical trial design

doi : 10.1016/S2468-1253(24)00439-4

Buy The Package and View The Article Online


Do you want to add Medilib to your home screen?